SCHEMBL20329200

SCHEMBL20329200

B[C@@H]1O[C@H](COP(=O)(S)OC2[C@@H](COC)O[C@@H](B)[C@H]2F)C(OC)[C@@H]1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26474211 1.00 — —
SCHEMBL24211093 0.85 — —
SCHEMBL20329196 0.85 — —
SCHEMBL26474225 0.85 — —
SCHEMBL12173554 0.82 — —
SCHEMBL21202665 0.82 — —
SCHEMBL21202667 0.82 — —
SCHEMBL15964501 0.82 — —
SCHEMBL22317545 0.82 — —
SCHEMBL14537229 0.82 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180177814-A1 EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT 2018-06-28 — — US disclosed
Send feedback